Loading
Extracellular Vesicles in Disease / Ferroptosis and Cancer Prognosis · Journal article
Medicina · August 11, 2026
Raises a question worth testing. It does not answer one.
This narrative review surveys the current understanding of exosome biology in colorectal cancer and proposes their potential as diagnostic, prognostic, and therapeutic tools. It does not present primary empirical evidence or clinical outcome data, but rather synthesizes existing knowledge and identifies future directions for translation to clinical practice.
Journal article. Colorectal cancer (general; not a study population).
Exosomes mediate tumor progression, metastatic dissemination, immune evasion, and therapeutic resistance through transfer of bioactive molecules including proteins, lipids, and non-coding RNAs Exosomes have gained attention as promising liquid biopsy tools and therapeutic platforms due to stability, biocompatibility, and ability to reflect tumor molecular dynamics
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review identifies exosomes as an emerging research area with potential translational applications in colorectal cancer diagnosis, prognosis, and treatment. Clinicians should regard these as investigational tools requiring further empirical validation before clinical integration.
This is a narrative review synthesizing mechanistic understanding and emerging applications of exosomes in colorectal cancer; it raises questions about clinical utility rather than answering them with empirical evidence.
This review identifies exosomes as an emerging research area with potential translational applications in colorectal cancer diagnosis, prognosis, and treatment. Clinicians should regard these as investigational tools requiring further empirical validation before clinical integration.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide despite advances in screening, surgical techniques, and systemic therapies. In recent years, exosomes—nanoscale extracellular vesicles involved in intercellular communication—have emerged as critical regulators of CRC biology. Exosomes mediate tumor progression, metastatic dissemination, immune evasion, and therapeutic resistance through the transfer of bioactive molecules including proteins, lipids, and non-coding RNAs. Moreover, exosomes have gained increasing attention as promising liquid biopsy tools and therapeutic platforms due to their stability, biocompatibility, and ability to reflect tumor molecular dynamics. This review provides a comprehensive overview of exosome biogenesis, molecular composition, and their functional roles in CRC pathogenesis. We further discuss their diagnostic and prognostic value, involvement in therapeutic resistance, and emerging therapeutic applications, with particular emphasis on translational and surgical oncology implications. Finally, we highlight current limitations and future perspectives for clinical integration of exosome-based strategies in CRC management.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.